"The Libin Cardiovascular Institute connects all cardiovascular research, clinical care and education in Southern Alberta. We are an entity of the University of Calgary and Alberta Health Services."

During the past decade, Libin Cardiovascular Institute of Alberta conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Libin Cardiovascular Institute of Alberta" #1 sponsor was "Ottawa Heart Institute Research Corporation" with 4 trials, followed by "Milestone Pharmaceuticals Inc." with 2 trials sponsored, "University of Calgary" with 2 trials sponsored, "Anthony Tang" with 1 trials sponsored and "Centre hospitalier de l'Université de Montréal (CHUM)" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Libin Cardiovascular Institute of Alberta" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 6 trials as a collaborator, "Medtronic" with 3 trials as a collaborator, "Heart and Stroke Foundation of Canada" with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator and "Alberta Innovation and Science" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Libin Cardiovascular Institute of Alberta" are "Atrial Fibrillation" (4 trials), "Cardiac Sarcoidosis" (2 trials), "Cardiomyopathies" (2 trials), "Paroxysmal Supraventricular Tachycardia" (2 trials) and "Arrhythmogenic Right Ventricular Cardiomyopathy" (1 trials). Many other conditions were trialed in "Libin Cardiovascular Institute of Alberta" in a lesser frequency.

Most popular intervention types in "Libin Cardiovascular Institute of Alberta" are "Device" (5 trials), "Drug" (5 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amiodarone (Antiarrhythmic drug)" (1 trials), "Aptar Pharma Nasal Spray Bidose System" (1 trials), "Catheter ablation" (1 trials), "Conventional CRT" (1 trials) and "Etripamil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Libin Cardiovascular Institute of Alberta" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Libin Cardiovascular Institute of Alberta". 1 are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Libin Cardiovascular Institute of Alberta, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Libin Cardiovascular Institute of Alberta, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".